Loading...
Medlab Clinical Limited
MDC.AX•ASX
Healthcare
Biotechnology
A$6.60
A$0.00(0.00%)
Medlab Clinical Limited (MDC.AX) Financial Performance & Income Statement Overview
Review Medlab Clinical Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-98.67%
↓ 98.67%
Operating Income Growth
68.76%
↑ 68.76%
Net Income Growth
68.57%
↑ 68.57%
Operating Cash Flow Growth
100.00%
↑ 100.00%
Operating Margin
-18989.10%
↓ 18989.10%
Gross Margin
278.92%
↑ 278.92%
Net Profit Margin
-17913.57%
↓ 17913.57%
ROE
274.67%
↑ 274.67%
ROIC
265.44%
↑ 265.44%
Medlab Clinical Limited (MDC.AX) Income Statement & Financial Overview
Review Medlab Clinical Limited's (MDC.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $866.00 | $11028.00 | $331066.00 | $165533.00 |
| Cost of Revenue | $866.00 | -$22147.00 | $1.47M | $27920.00 |
| Gross Profit | $0.00 | $33175.00 | -$1.14M | $137613.00 |
| Gross Profit Ratio | $0.00 | $3.008 | -$3.45 | $0.83 |
| R&D Expenses | $0.00 | $0.00 | $89039.00 | $44520.00 |
| SG&A Expenses | $225487.00 | $2.05M | $1.96M | $1.34M |
| Operating Expenses | $241287.00 | $2.03M | $1.49M | $931636.00 |
| Total Costs & Expenses | $241286.00 | $2.03M | $2.97M | $959556.00 |
| Interest Income | $0.00 | $241.00 | $0.00 | $21.00 |
| Interest Expense | $45.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $90094.00 | $58460.00 | $3493.00 | $135144.00 |
| EBITDA | -$150326.00 | -$2.02M | -$2.64M | -$1.13M |
| EBITDA Ratio | -$173.59 | -$183.001 | -$7.95 | -$6.85 |
| Operating Income | -$240420.00 | -$2.02M | -$2.64M | -$1.18M |
| Operating Income Ratio | -$277.62 | -$183.002 | -$7.96 | -$7.15 |
| Other Income/Expenses (Net) | $90049.00 | $37584.00 | -$21740.00 | $393546.00 |
| Income Before Tax | -$150371.00 | -$1.98M | -$2.66M | -$789277.00 |
| Income Before Tax Ratio | -$173.64 | -$179.59 | -$8.03 | -$4.77 |
| Income Tax Expense | $0.00 | $0.00 | -$1.08M | $192.00 |
| Net Income | -$150371.00 | -$1.98M | -$1.96M | -$981172.00 |
| Net Income Ratio | -$173.64 | -$179.57 | -$5.93 | -$5.93 |
| EPS | -$0.07 | -$0.43 | -$0.43 | -$0.43 |
| Diluted EPS | -$0.07 | -$0.43 | -$0.43 | -$0.43 |
| Weighted Avg Shares Outstanding | $2.28M | $2.28M | $2.28M | $2.28M |
| Weighted Avg Shares Outstanding (Diluted) | $2.28M | $2.28M | $2.28M | $2.28M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan